View All Key Stats
ABBV Key Stats
| Income Statement | |
| Revenue (TTM) | 26.22B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 3.86 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 6.31B |
| Profitability | |
| Gross Profit Margin (Quarterly) | 75.28% |
| Profit Margin (Quarterly) | 26.17% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 3.30% |
| Price and Valuation | |
| Market Cap | 116.56B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 4.539 |
| PE Ratio (TTM) | 18.97 |
| Price to Book Value | 23.32 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | 7.393 |
| Free Cash Flow (Quarterly) | 2.007B |
| Return on Equity (TTM) | 119.6% |
View All ABBV News
ABBV News
-
WireHeadlineTime (ET)
-
MT Newswires06/23 09:16
-
PR Newswire06/23 08:47
-
MT Newswires06/23 08:12
-
Yahoo06/23 05:53
-
Yahoo06/22 23:27
-
Yahoo06/22 18:50
-
SA Breaking News06/22 16:04
-
MT Newswires06/22 16:00
-
PR Newswire06/22 15:52
-
Yahoo06/22 14:47
View All Events
ABBV Events
| Date | Type | Description |
|---|---|---|
| 05/05/2017 09:00 CDT | Misc | AbbVie Inc Annual General Meeting in 2016 |
| 04/27/2017 08:00 CDT | Misc | AbbVie Inc First Quarter Earnings Conference Call in 2017 |
| 04/27/2017 | Earnings | AbbVie Inc First Quarter Earnings in 2017 Release |
| 04/11/2017 | Dividends | Amount: 0.64, Declared Date: Feb 16 2017, Pay Date: May 15 2017 |
| 01/27/2017 08:00 CDT | Misc | AbbVie Inc Fourth Quarter Earnings Conference Call in 2016 |
| 01/27/2017 | Earnings | AbbVie Inc Fourth Quarter Earnings in 2016 Release |
| 01/11/2017 | Dividends | Amount: 0.64, Declared Date: Oct 28 2016, Pay Date: Feb 15 2017 |
| 10/28/2016 08:00 CDT | Misc | AbbVie Inc Third Quarter Earnings Conference Call in 2016 |
| 10/28/2016 | Earnings | AbbVie Inc Third Quarter Earnings in 2016 Release |
| 10/12/2016 | Dividends | Amount: 0.57, Declared Date: Sep 09 2016, Pay Date: Nov 15 2016 |
ABBV Fundamentals
Income Statement View Statement
ABBV Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
ABBV One Page Reports
- One Page Report Download
ABBV Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Target Price | |
| Price | 73.24 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.abbvie.com
- Investor Relations URL: http://www.abbvieinvestor.com/phoenix.zhtml?c=251551&p=irol-IRHome
- HQ State/Province: Illinois
- Sector: Healthcare
- Industry: Drug Manufacturers - Major
- Next Earnings Release: N/A
- Last Earnings Release: Apr. 27, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Apr. 11, 2017
- Description: AbbVie Inc is a biopharmaceutical company that discovers, develops, manufactures and sells a range of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders.
ABBV Comparables
EditABBV Excel Add-In Codes
- Name: =YCI("ABBV","name")
- Description: =YCI("ABBV","description")
- Sector: =YCI("ABBV","sector")
- Industry: =YCI("ABBV","industry")
- Est. Current Fiscal Year End: =YCI("ABBV","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other ABBV Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- ABBV Tweets Stocktwits
Advertisement
